Skip to main content

Neural Factors and Ventricular Electrical Instability

  • Chapter
Sudden Death

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 4))

Abstract

Coronary care unit and out-of-hospital resuscitation experience have made it clear that ventricular fibrillation (VF) is the main mechanism for sudden cardiac death. Since prolonged survival is possible after resuscitation, this lethal arrhythmia represents an electrical accident rather than the end-product of far advanced, irreversible structural disease of the heart (1). In most cases of sudden death, acute pathologic lesions either in the coronary arteries or in the myocardium are absent or inadequate to account for the fatal event. How, then, is the derangement in electrical activity of the heart precipitated?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lown B: Sudden death from coronary heart disease. In: Early phases of coronary heart disease, Walden-ström, Larsson, Ljungstedt (eds), Stockholm, Nordiska Bokhandelns Forlag, 1973, p 255–277.

    Google Scholar 

  2. Lown B, Verrier RL: Neural activity and ventricular fibrillation. N Engl J Med 294: 1165–1170, 1976.

    Article  PubMed  CAS  Google Scholar 

  3. Wolff GA, Veith F, Lown B: A vulnerable period for ventricular tachycardia following myocardial infarction. Cardiovasc Res 2: 111–121, 1968.

    Article  PubMed  CAS  Google Scholar 

  4. Thompson PL, Lown B: Sequential R/T pacing to expose electrical instability in the ischemic ventricle. Clin Res 20: 401, 1972.

    Google Scholar 

  5. Axelrod PJ, Verrier RL, Lown B: Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release. Am J Cardiol 36: 776–782, 1976.

    Article  Google Scholar 

  6. Matta, RJ, Verrier RL, Lown B: The repetitive extrasystole as an index of vulnerability to ventricular fibrillation. Am J Physiol 230: 1469–1473, 1976.

    PubMed  CAS  Google Scholar 

  7. Verrier RL, Brooks WW, Lown B: Protective zone and the determination of vulnerability to ventricular fibrillation. Am J Physiol 234: H592–H596, 1978.

    PubMed  CAS  Google Scholar 

  8. Greene HL, Reid PR, Schaeffer AH: The repetitive ventricular response in man: A predictor of sudden death. N Engl J Med 299: 729–734, 1978.

    Article  PubMed  CAS  Google Scholar 

  9. Farshidi A, Michelson EL, Greenspan AM, Spielman SR, Kastor JA, Horowitz LN, Josephson ME: Repetitive responses to ventricular extrastimuli-incidence, mechanism and significance. Am J Cardiol 43: 390, 1979.

    Google Scholar 

  10. Greene HL, Reid PR, Schaeffer AH: The repetitive ventricular response in man-a new predictor of sudden death and symptomatic ventricular tachycardia. In: Management of ventricular tachycardia-role of mexiletine, Sande E, Julian DG, Bell JW (eds), Amsterdam, Excerpta Medica (International Congress Series no 458) 1978, p 513–526.

    Google Scholar 

  11. Lown B, Verrier RL, Blatt CM: Precordial mechanical stimulation for exposing electrical instability of the heart. Am J Cardiol 42: 425–428, 1978.

    Article  PubMed  CAS  Google Scholar 

  12. Lown B, Verrier RL, Rabinowitz SH: Neural and psychologie mechanisms and the problem of sudden cardiac death. Am J Cardiol 39: 890–902, 1977.

    Article  PubMed  CAS  Google Scholar 

  13. Hoff EC, Kell JF, Carroll MN: Effects of cortical stimulation and lesions on cardiovascular function. Physiol Rev 43: 68–114, 1963.

    PubMed  CAS  Google Scholar 

  14. Korteweg GCJ, Boeles TF, Tencate J: Influence of stimulation of some subcortical areas on electrocardiogram. J Neurophysiol 20: 100–107, 1957.

    PubMed  Google Scholar 

  15. Verrier RL, Calvert A, Lown B: Effect of posterior hypothalamic stimulation on the ventricular fibrillation threshold. Am J Physiol 228: 923–927, 1975.

    PubMed  CAS  Google Scholar 

  16. Satinsky J, Kosowsky B, Lown B, Kerzner J: Ventricular fibrillation induced by hypothalamic stimulation during coronary occlusion. Circulation 44: 11–60, 1971.

    Google Scholar 

  17. Manning JW, Cotten MD: Mechanism of cardiac arrhythmias induced by diencephalic stimulation. Am J Physiol 203: 1120–1124, 1962.

    Google Scholar 

  18. Hockman CH, Mauck HP, Hoff EC: ECG changes resulting from cerebral stimulation: II. A spectrum of ventricular arrhythmias of sympathetic origin. Am Heart J 71: 695–700, 1966.

    Article  PubMed  CAS  Google Scholar 

  19. Korteweg GCJ, Boeles TF, Tencate J: Influence of stimulation of some subcortical areas on electrocardiogram. J Neurophysiol 20: 100–107, 1957.

    PubMed  Google Scholar 

  20. Evans DE, Gillis RA: Reflex mechanisms involved in cardiac arrhythmias induced by hypothalamic stimulation. Am J Physiol 234: H199–H209, 1978.

    PubMed  CAS  Google Scholar 

  21. Han J, Garcia de Jalon P, Moe GK: Adrenergic effects on ventricular vulnerability. Circ Res 14: 516–524, 1964.

    PubMed  CAS  Google Scholar 

  22. Verrier RL, Thompson P, Lown B: Ventricular vulnerability during sympathetic stimulation: Role of heart rate and blood pressure. Cardiovasc Res 8: 602–610, 1974.

    Article  PubMed  CAS  Google Scholar 

  23. Brooks WW, Verrier RL, Lown B: Influence of vagal tone on stellectomy-induced changes in ventricular electrical stability. Am J Physiol 234:HSO3–HSO7, 1978.

    Google Scholar 

  24. Harris AS, Otero H, Bocage A: The induction of arrhythmias by sympathetic activity before and after occlusion of a coronary artery in the canine heart. J Electrocardiol 4: 34–43, 1971.

    Article  PubMed  CAS  Google Scholar 

  25. Yanowitz F, Preston JB, Abildskov JA: Functional distribution of right and left stellate innervation to the ventricles: production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Circ Res 18: 416–428, 1966.

    PubMed  CAS  Google Scholar 

  26. Verrier RL, Lown B: Influence of neural activity on ventricular electrical instability during acute myocardial ischemia and infarction. In: Management of ventricular tachycardia — role of mexiletine, Sande E, Julian DG, Bell JW (eds), Amsterdam, Excerpta Medica (International Congress Series no 458), 1978, p 133–150.

    Google Scholar 

  27. Schwartz PJ, Periti M, Malliani A: The long Q-T syndrome. Am Heart J 89: 378–390, 1975.

    Article  PubMed  CAS  Google Scholar 

  28. Moss A., Schwartz PJ, Sudden death and the idiopathic long Q-T syndrome. Am J 66: 6–7, 1979.

    Article  CAS  Google Scholar 

  29. Rabinowitz SH, Verrier RL, Lown B: Muscarinic effects of vagosympathetic trunk stimulation on the repetitive extrasystole threshold. Circulation 53: 622–627, 1976.

    PubMed  CAS  Google Scholar 

  30. Dale HH: On some physiologic actions of ergot. J Physiol (London) 34: 163–206, 1906.

    Google Scholar 

  31. Ahlquist RP: A study of the adrenotropic receptors. Am J Physiol 153: 586–600, 1948.

    PubMed  CAS  Google Scholar 

  32. Wit AL, Hoffman BF, Rosen MR: Electrophysiology and pharmacology of cardiac arrhythmias: IX. Parts A, B, C. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Am Heart J 90:521–533, 665–675, 795–803, 1975.

    Google Scholar 

  33. Gould L, Reddy CVR, Weinstein T, et al: Antiarrhythmic prophylaxis with phentolamine in acute myocardial infarction. J Clin Pharmacol 15: 191–197, 1975.

    Google Scholar 

  34. Gould L,Gomprecht RF, Zahir M: Oral phentolamine for treatment of ventricular premature contractions. Br Heart J 33: 101–104, 1971.

    Article  Google Scholar 

  35. Gould L, Zahir M, Shariff M: Treatment of cardiac arrhythmias with phentolamine. Am Heart J 78: 189–193, 1969.

    Article  PubMed  CAS  Google Scholar 

  36. DiMicco JA, Prestel T, Pearle DL, Gillis RA: Mechanism of cardiovascular changes produced in cats by activation of the central nervous system with picrotoxin. Circ Res 41: 446–451, 1977.

    PubMed  CAS  Google Scholar 

  37. Zipes D. Elharrar V, Watanabe AM, et al: Induction of ventricular fibrillation in probucol-treated dogs. Clin Res 25: 459A, 1977.

    Google Scholar 

  38. Nickerson M, Collier B: Drugs inhibiting adrenergic nerves and structures innervated by them. In: The pharmacologic basis of therapeutics, Goodman LS, Gilman A (eds), New York City, The Macmillan Company, 1968, p 546–577.

    Google Scholar 

  39. Nickerson M, Brown HO: Protection by dibenamine against “spontaneous” arrhythmias occurring during cycloproprane anesthesia. Anesthesiol 12: 216–224, 1949.

    Article  Google Scholar 

  40. Casscells W, Verrier RL, Lown B:,Influence of phentolamine on ventricular vulnerability and spontaneous defibrillation in the cat (abstract). Am J Cardiol 43: 375, 1979.

    Google Scholar 

  41. Rosen MR, Gelband H, Hoffman BF: Effects of phentolamine on electrophysiologic properties of isolated canine Purkinje fibers. J Pharmacol Exp Ther 170: 586–593, 1971.

    Google Scholar 

  42. Majid PA, Saxton C, Dykes JRW, Galvin MC, Taylor SH: Autonomic control of insulin secretion and the treatment of heart failure. Br Med J 4: 320–333, 1970.

    Article  Google Scholar 

  43. Pfister B, Imhof PR: Inhibition of adrenalin-induced platelet aggregation by the orally administered alphaadrenergic receptor blocker phentolamine (Regitinee). Europ J Clin Pharmacol 11: 7–10, 1977.

    Article  CAS  Google Scholar 

  44. Levene DL, Freeman MR: Alpha-adrenoreceptor-mediated coronary artery spasm. JAMA 236: 1018–1022, 1976.

    Article  PubMed  CAS  Google Scholar 

  45. Fondacro JD, Han J, Yoon MS: Effects ofverapamil on ventricular rhythm during acute coronary occlusion. Am Heart J 96: 81–86, 1978.

    Article  Google Scholar 

  46. Melville KI, Shister HE, Huq S: Iproveratril: Experimental data on coronary dilatation and antiarrhythmic action. Can Med Assoc J 90: 761–769, 1964.

    PubMed  CAS  Google Scholar 

  47. Melville KI, Bewfey BG: Coronary vasodilatory and cardiac adrenergic blocking effects of iproveratril. Can J Physiol Pharmacol 43: 339–342, 1965.

    Article  PubMed  CAS  Google Scholar 

  48. Garvey HL, Melville KI: Effect of verapamil on cardiovascular responses to lateral hypothalamic stimulation in normal and coronary-ligated dogs. Can J Physiol Pharmacol 47: 675–684, 1969.

    Article  PubMed  CAS  Google Scholar 

  49. Melville KI, Garvey HL, Shister HE: On the cardiac adrenergic blocking action of iproveratril in normal and coronary-ligated dogs. Rev Can Biol 27: 225–235, 1968.

    PubMed  CAS  Google Scholar 

  50. Huang TF, Peng YI: Effect of verapamil on experimental arrhythmias. Europ J Pharmacol 42: 363–370, 1977.

    Article  CAS  Google Scholar 

  51. Brooks WW, Verrier RL, Lown B: Protective effect of verapamil on ventricular vulnerability during coronary artery occlusion and reperfusion (abstract). Am J Cardiol. 41: 426, 1978.

    Article  Google Scholar 

  52. Naylor WG. Szeto J: Effect of verapamil on contractility, oxygen utilization and calcium exchangeability in mammalian heart muscle. Cardiovasc Res 6: 120–128, 1972.

    Article  Google Scholar 

  53. Watanabe AM, Besch HR: Subcellular myocardial effects of verapamil and D600: Comparison with propranolol. J Pharmacol Exp Ther 191: 241–251, 1974.

    PubMed  CAS  Google Scholar 

  54. Haeusler G: Differential effect of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. J Pharmacol Exp Ther 180: 672–682, 1972.

    PubMed  CAS  Google Scholar 

  55. Malliani A, Schwartz PJ, Zanchetti A: A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 217: 703–709, 1969.

    PubMed  CAS  Google Scholar 

  56. Kelliher GJ, Widmer C, Roberts J: Influence of the adrenal medulla on cardiac rhythm disturbances following acute coronary artery occlusion. Recent Adv Stud Cardiac Struct Metab 10: 387–400, 1975.

    PubMed  CAS  Google Scholar 

  57. Corbalan R, Verrier RL, Lown B: Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am Heart J 92: 223–230, 1976.

    Article  PubMed  CAS  Google Scholar 

  58. Khan MI, Hamilton JT, Manning GW: Protective effect of beta-adrenoceptor blockade in experimental occlusion in conscious dogs. Am J Cardiol 30: 832–837, 1972.

    Article  PubMed  CAS  Google Scholar 

  59. Fitzgerald JD: Role of adrenergic blockade. In: Effect of acute ischaemia on myocardial function. Oliver MF, Julian DG, Donald KW (eds), Baltimore, Williams and Wilkins Co, 1972, p 321–351.

    Google Scholar 

  60. Hai HA, Temte JV, Lown B: Changes in ventricular fibrillation threshold during coronary artery occlusion and release induced by beta-adrenergic blockade (abstract). Am J Cardiol 37: 140, 1976.

    Article  Google Scholar 

  61. Pearle DL, Williford D, Gillis RA: Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion. Am J Cardiol 42: 960–964, 1978.

    Article  PubMed  CAS  Google Scholar 

  62. Yasue H: Beta-adrenergic blockade and coronary arterial spasm. In: Management of ventricular tachycardia — role of mexiletine, Sande E, Julian DG, Bell JW (eds), Amsterdam, Excerpta Medica (International Congress Series no 458), 1978, p 305–310.

    Google Scholar 

  63. Norris RM, Congbey DE, Scott PJ: A trial of propranolol in acute myocardial infarction. Br Med J 2: 398–400, 1968.

    Article  PubMed  CAS  Google Scholar 

  64. Oliva PB, Breckinridge JC: Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation 56: 366–374, 1977.

    PubMed  CAS  Google Scholar 

  65. Maseri A, L’Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Parodi O, Biazini A, Distante A, Pesola A: Coronary vasospasm: A possible cause of myocardial infarction: A conclusion derived from the study of “Preinfarction Angina. ” N Engl J Med 299: 1221–1277, 1978.

    Article  Google Scholar 

  66. Braunwald E: Coronary spasm and acute myocardial infarction — new possibility for treatment and prevention. N Engl J Med 299: 1301–1303, 1978.

    Article  PubMed  CAS  Google Scholar 

  67. Mudge GH, Goldberg S, Gunther S: Comparison of metabolic and vasoconstrictor stimuli on coronary vascular resistance in man. Circulation 59: 544–550, 1979.

    PubMed  Google Scholar 

  68. Mohrman DE, Feigl EO: Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 42: 79–86, 1978.

    PubMed  Google Scholar 

  69. Schwartz PJ, Stone HL: Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs. Circ Res 41: 51–58, 1977.

    PubMed  CAS  Google Scholar 

  70. Penkoske PA, Sobel BE, Corr PB: Inhibition by alpha-adrenergic blockade of the ventricular dysrhythmias induced by reperfusion. Clin Res 26: 259A, 1978.

    Google Scholar 

  71. Sheridan DJ, Penkoske PA, Corr PB: Specific antiarrhythmic effectiveness of alpha-adrenergic blockade during coronary reperfusion. Am J Cardiol 43: 372, 1979.

    Google Scholar 

  72. Stewart JR, Burmeister WE, Burmeister JL, Lucchesi BR: Electrophysiologic and antiarrhythmic effects of phentolamine in experimental coronary artery occlusion and reperfusion in the dog. Am J Cardiol 43: 359, 1979.

    Google Scholar 

  73. Schoeneberger A, Verrier RL, Lown B: Protective effect of prenylamine on ventricular vulnerability in the normal and ischemic canine myocardium. Proc Soc Exp Biol Med, 161: 56–59, 1979.

    PubMed  CAS  Google Scholar 

  74. Stockman MB, Verrier RL, Lown B: Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am J Cardiol 43: 233–238, 1979.

    Article  PubMed  CAS  Google Scholar 

  75. Elharrar V, Gaum WE, Zipes D: Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Am J Cardiol 39: 544–549, 1977.

    Article  PubMed  CAS  Google Scholar 

  76. Kent KM, Smith ER, Redwood DR, Epstein SE: Beneficial electrophysiologic effects of nitroglycerin during acute myocardial infarction. Am J Cardiol 33: 513–516, 1974.

    Article  PubMed  CAS  Google Scholar 

  77. Levites R, Boderheimer MM, Helfant RHL: Electrophysiologic effects of NTG during experimental coronary occlusion. Circulation 52: 1050–1055, 1975.

    PubMed  CAS  Google Scholar 

  78. Higgins CB, Vatner SF, Braunwald E: Parasympathetic control of the heart. Pharmacol Rev 25: 119–155, 1973.

    PubMed  CAS  Google Scholar 

  79. Kent KM, Smith ER, Redwood DR, Epstein SE: Electrical stability of acutely ischemic myocardium: Influences of heart rate and vagal stimulation. Circulation 47: 291–298, 1973.

    PubMed  CAS  Google Scholar 

  80. Kent KM, Epstein SE, Cooper T, Jacobowitz DM: Cholinergic innervation of the canine and human ventricular conducting system: Anatomic and electrophysiologic correlation. Circulation 50: 948–955, 1974.

    PubMed  CAS  Google Scholar 

  81. Kolman BS, Verrier RL, Lown B: The effect of vagus nerve stimulation upon vulnerability of the canine ventricle. Role of sympathetic-parasympathetic interactions. Circulation 52: 578–585, 1975.

    PubMed  CAS  Google Scholar 

  82. Levy MN, Blattberg B: Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 38: 81–85, 1976.

    PubMed  CAS  Google Scholar 

  83. Watanabe AM, Besch HR: Interaction between cyclic adenosine monophosphate and cyclic guanosine monophosphate in guinea pig ventricular myocardium. Circ Res 37: 309–317, 1975.

    PubMed  CAS  Google Scholar 

  84. Tse WW, Han J, Yoon MS: Effect of acetylcholine on automaticity of canine Purkinje fibers. Am J Physiol 203: 116–119, 1976.

    Google Scholar 

  85. Vassalle M: Cardiac automaticity and its control. Am J Physiol 2: H625–H634, 1977.

    Google Scholar 

  86. Weiss T, Lattin GM, Engelman K: Vagally mediated suppression of premature ventricular contractions in man. Am Heart J 89: 700–707, 1975.

    Article  PubMed  CAS  Google Scholar 

  87. Waxman MB, Wald RW: Termination of ventricular tachycardia by an increase in cardiac vagal drive. Circulation 56: 385–391, 1977.

    PubMed  CAS  Google Scholar 

  88. Weiss T, Mancia G, Delbo A, Cavoretto D, Grazi S, Preti J, Schwartz Pi. The role of heart rate in the phenylephrine-induced suppression of premature ventricular beats. (Abstract). Eur. J Clin. Invest 9: 39, 1979.

    Google Scholar 

  89. Lown B, Tykocinski M, Garfein A, Brooks P: Sleep and ventricular premature beats. Circulation 48: 691–701, 1973.

    PubMed  CAS  Google Scholar 

  90. Baust W, Bohnert B: The regulation of heart rate during sleep. Exp Brain Res 7: 169–180, 1969.

    Article  PubMed  CAS  Google Scholar 

  91. Corr PB, Gillis RA: Role of the vagus in the cardiovascular changes induced by coronary occlusion. Circulation 49: 86–97, 1974.

    PubMed  CAS  Google Scholar 

  92. Corr PB, Pearle DL, Gillis RA: Coronary occlusion site as a determinant of the cardiac rhythm effects of atropine and vagotomy. Am Heart J 92: 741–749, 1976.

    Article  PubMed  CAS  Google Scholar 

  93. Yoon MS, Han J. Tse WW, Rogers R: Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. Am Heart J 93: 60–65, 1977.

    Article  PubMed  CAS  Google Scholar 

  94. James RGG, Arnold JMO, Allen JD, Pantridge JF, Shanks RG: The effects of heart rate, myocardial ischemia and vagal stimulation on the threshold for ventricular fibrillation. Circulation 55: 311–317, 1977.

    PubMed  CAS  Google Scholar 

  95. Corr PB, Penkoske PA, Sobel BE: Adrenergic influences on arrhythmias due to coronary occlusion and reperfusion. Br Heart J 40 (suppl): 62–70, 1978.

    Google Scholar 

  96. Verrier RL, Brooks WW, Lown B: Effect of cholinergic stimulation on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion (abstract). Am J Cardiol 41: 366, 1978.

    Article  Google Scholar 

  97. Verrier RL, Lown B: Sympathetic-parasympathetic interactions and ventricular electrical stability. In: Neural mechanisms in cardiac arrhythmias. Schwartz PJ, Brown AM, Malliani A, Zanchetti A (eds), New York City, Raven Press, 1978, p 75–85.

    Google Scholar 

  98. Kerzner J, Wolf M, Kosowsky BD, Lown B: Ventricular ectopic rhythms following vagal stimulation in dogs with acute myocardial infarction. Circulation 47: 44–50, 1973.

    PubMed  CAS  Google Scholar 

  99. El-Sherif N: Reentrant ventricular arrhythmias in the late myocardial infarction period: VI. Effect of the autonomic system. Circulation 58: 103–110, 1978.

    PubMed  CAS  Google Scholar 

  100. Pantridge JF, Adgey AAJ, Geddes JS, Webb SW: The acute coronary attack, New York City, Grune & Stratton, 1975.

    Google Scholar 

  101. Webb SW, Adgey AAJ, Pantridge JF: Autonomic disturbance at onset of myocardial infarction. Br Med J 3: 89–92, 1972.

    Article  PubMed  CAS  Google Scholar 

  102. Biorck G, Erhardt LR: The earliest phase of acute myocardial infarction in man. Acta Med Scand 193: 251–255, 1973.

    Article  PubMed  CAS  Google Scholar 

  103. Lown B, Verrier RL, Corbalan R: Psychologie stress and threshold for repetitive ventricular response. Science 182: 834–836, 1973.

    Article  PubMed  CAS  Google Scholar 

  104. Liang B, Verrier RL, Lown B, Melman J: Correlation between circulating catecholamine levels and ventricular vulnerability during psychological stress in conscious dogs. Proc Soc Exptl. Biot Med. 161: 266–269, 1979.

    CAS  Google Scholar 

  105. Matta RJ, Lawler JE, Lown B: Ventricular electrical instability in the conscious dog: effects of psychologie stress and beta adrenergic blockade. Am J Cardiol 38: 594–598, 1976.

    Article  PubMed  CAS  Google Scholar 

  106. Verrier RL, Lown B: Effect of left stellectomy on enhanced cardiac vulnerability induced by psychologie stress (abstract). Circulation 56: 111–80, 1977.

    Google Scholar 

  107. Verrier RL, Lown B: Influence of stellectomy and beta-adrenergic blockade on ventricular vulnerability during psychologie stress in the canine model. In preparation. 1978.

    Google Scholar 

  108. DeSilva RA, Verrier RL, Lown B: Effect of psychologie stress and sedation with morphine sulfate on ventricular vulnerability. Am Heart J 95: 197–203, 1978.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Martinus Nijhoff Publishers bv, The Hague

About this chapter

Cite this chapter

Verrier, R.L. (1980). Neural Factors and Ventricular Electrical Instability. In: Kulbertus, H.E., Wellens, H.J.J. (eds) Sudden Death. Developments in Cardiovascular Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8834-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8834-7_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8836-1

  • Online ISBN: 978-94-009-8834-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics